A method for the synthesis of hydroxamic acids on solid phase

被引:93
作者
Floyd, CD
Lewis, CN
Patel, SR
Whittaker, M
机构
[1] British Biotech Pharmaceutical Ltd, Oxford, OX4 5LY, Watlington Rd
关键词
D O I
10.1016/0040-4039(96)01821-7
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Wang resin 1 was modified using a Mitsunobu reaction to give resin bound O-hydroxylamine 3. This resin was acylated and the adduct cleaved from the resin as a hydroxamic acid on treatment with TFA. Series of tripeptide, and sulfonamido 9 hydroxamic acids which act as inhibitors of metalloproteinases have been prepared. Resins more sensitive to acid cleavage can also be modified to simplify the work-up procedure. Copyright (C) 1996 Elsevier Science Ltd
引用
收藏
页码:8045 / 8048
页数:4
相关论文
共 12 条
[1]  
Atherton E, 1989, SOLID PHASE SYNTHESI
[2]   Recent advances in matrix metalloproteinase inhibitor research [J].
Beckett, RP ;
Davidson, AH ;
Drummond, AH ;
Huxley, P ;
Whittaker, M .
DRUG DISCOVERY TODAY, 1996, 1 (01) :16-26
[3]  
Cody D.R., 1994, U.S. Patent, Patent No. [5,324,483, 5324483]
[4]  
Floyd CD, 1996, CHEM BRIT, V32, P31
[5]  
Johnson W H, 1987, J Enzyme Inhib, V2, P1, DOI 10.3109/14756368709030352
[6]   NEW COUPLING REAGENTS IN PEPTIDE CHEMISTRY [J].
KNORR, R ;
TRZECIAK, A ;
BANNWARTH, W ;
GILLESSEN, D .
TETRAHEDRON LETTERS, 1989, 30 (15) :1927-1930
[7]  
MacPherson LJ, 1994, [No title captured], Patent No. [EP606.046A1, 606046]
[8]  
MILLER A, 1995, Patent No. 9535275
[9]  
MILLER A, 1995, Patent No. 9535276
[10]  
ODAKE S, 1990, CHEM PHARM BULL, V38, P1007